Pasqualoni M, Orlandi A, Palazzo A, et al. Case report: vitiligolike toxicity due to ribociclib during first-line treatment of
metastatic...
Gao S, Wei G, Hao Y. Vitiligo-like lesions induced by cyclindependent kinase 4/6 inhibitor Palbociclib: a case report and
literature review....
Silvestre Torner N, Aguilar Martínez A, Echarri González MJ,
et al. Ribociclib-induced vitiligo: a case report. Dermatol Pract
Concept 2022;12(2):e20220045....
Sharaf B, AlMasri R, Abdel-Razeq N, et al. Vitiligo-like lesions
in a patient with metastatic breast cancer treated with cyclindependent kinase...
Desnoyers A, Nadler MB, Kumar V, et al. Comparison of
treatment-related adverse events of different cyclin-dependent kinase 4/6 inhibitors...
Hecht KA, Selby C. Review of cyclin-dependent kinase 4/6
inhibitors for the treatment of hormone receptor–positive
advanced breast cancer....
Raschi E, Fusaroli M, La Placa M, et al. Skin toxicities with
cyclin-dependent kinase 4/6 inhibitors in breast cancer:
Signals from disproportionality...
Alsatti H, AlMalki B, Alghamdi Y. Abemaciclib-associated skin,
hair, and nail toxicities: a case report. Cureus. 2024;16(4):
e57677. https://doi.org/10.7759/cureus.57677.
Anjaneyan G, Keechilat P, Duraisamy P, et al. Ribociclibinduced extensive vitiligo-like lesions: possible
pathomechanisms with clinical, dermoscopic...
Chan OB, Su JC, Yazdabadi A, et al. Drug induced vitiligo-like
depigmentation from a CDK 4/6 inhibitor. Asia Pac J Clin
Oncol. 2022;18(2):...
Sibaud V, Sollena P. Dermatologic toxicities to inhibitors of
cyclin-dependent kinases CDK 4 and 6: an updated review for
clinical practice....
Pu D, Wu Y, Xu D, et al. The adverse events of CDK4/6
inhibitors for HR+/ HER2- breast cancer: an umbrella review of
meta-analyses of...
Menteþoðlu D. Photoallergic dermatitis and vitiligo-like lesion
in a patient with metastatic breast cancer using ribociclib.
Indian J Pharmacol...
Türkel A, Karaçin C, Öner İ, et al. Vitiligo-like lesions
associated with ribociclib in a woman with metastatic breast
cancer. J Oncol Pharm...
Bang AS, Fay CJ, LeBoeuf NR, et al. Multi-center retrospective
review of vitiligo-like lesions in breast cancer patients treated
with cyclin-dependent...
